🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/12/2010 | 63,40 | 64,07 | 62,62 | 63,86 | +0,52% | 2,29% | 217.300 |
| 23/12/2010 | 63,24 | 63,88 | 62,78 | 63,53 | +0,30% | 1,74% | 221.200 |
| 22/12/2010 | 63,60 | 64,13 | 62,86 | 63,34 | -0,55% | 2,00% | 300.500 |
| 21/12/2010 | 63,34 | 64,31 | 62,98 | 63,69 | +0,49% | 2,10% | 329.700 |
| 20/12/2010 | 63,69 | 64,15 | 61,56 | 63,38 | -0,27% | 4,07% | 582.800 |
| 17/12/2010 | 64,36 | 64,64 | 63,06 | 63,55 | -1,07% | 2,45% | 1.308.500 |
| 16/12/2010 | 64,10 | 64,27 | 63,02 | 64,24 | +0,45% | 1,95% | 350.400 |
| 15/12/2010 | 62,95 | 64,66 | 62,43 | 63,95 | +1,64% | 3,54% | 738.700 |
| 14/12/2010 | 62,45 | 63,30 | 62,00 | 62,92 | +0,61% | 2,08% | 243.100 |
| 13/12/2010 | 63,50 | 63,50 | 62,31 | 62,54 | -1,12% | 1,87% | 435.900 |
| 10/12/2010 | 62,19 | 63,50 | 61,86 | 63,25 | +1,98% | 2,64% | 416.000 |
| 09/12/2010 | 62,12 | 62,19 | 60,94 | 62,02 | +0,39% | 2,01% | 568.900 |
| 08/12/2010 | 62,26 | 63,25 | 61,75 | 61,78 | -0,83% | 2,41% | 1.069.900 |
| 07/12/2010 | 63,68 | 63,99 | 62,15 | 62,30 | -1,36% | 2,89% | 553.000 |
| 06/12/2010 | 62,48 | 63,35 | 61,90 | 63,16 | +1,10% | 2,32% | 517.700 |
| 03/12/2010 | 62,68 | 63,49 | 62,32 | 62,47 | -0,76% | 1,87% | 530.200 |
| 02/12/2010 | 62,06 | 63,01 | 61,77 | 62,95 | +0,80% | 2,00% | 339.100 |
| 01/12/2010 | 63,63 | 63,91 | 62,25 | 62,45 | -0,76% | 2,61% | 542.700 |
| 30/11/2010 | 61,93 | 63,05 | 61,57 | 62,93 | +0,59% | 2,39% | 579.400 |
| 29/11/2010 | 62,29 | 62,66 | 61,51 | 62,56 | -0,14% | 1,85% | 266.600 |
| 26/11/2010 | 62,54 | 62,95 | 62,39 | 62,65 | -0,93% | 0,90% | 97.300 |
| 24/11/2010 | 62,29 | 63,34 | 62,25 | 63,24 | +2,03% | 1,75% | 359.200 |
| 23/11/2010 | 62,15 | 62,64 | 61,61 | 61,98 | -1,24% | 1,66% | 475.400 |
| 22/11/2010 | 62,95 | 63,58 | 62,15 | 62,76 | -0,25% | 2,27% | 662.900 |
| 19/11/2010 | 62,32 | 63,68 | 61,37 | 62,92 | +1,45% | 3,71% | 849.500 |
| 18/11/2010 | 61,79 | 63,43 | 61,60 | 62,02 | +1,52% | 2,96% | 818.800 |
| 17/11/2010 | 60,81 | 61,12 | 60,20 | 61,09 | +0,68% | 1,51% | 392.500 |
| 16/11/2010 | 59,88 | 61,33 | 59,57 | 60,68 | +0,75% | 2,94% | 883.800 |
| 15/11/2010 | 59,82 | 60,88 | 59,68 | 60,23 | +0,87% | 2,01% | 628.300 |
| 12/11/2010 | 59,54 | 60,40 | 59,05 | 59,71 | -0,33% | 2,27% | 462.100 |